Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

An atypical pulmonary fibrosis is associated with co-inheritance of mutations in the calcium binding protein genes S100A3 and S100A13.

Al-Mutairy EA, Imtiaz FA, Khalid M, Al Qattan S, Saleh S, Mahmoud LM, Al-Saif MM, Al-Haj L, Al-Enazi A, AlJebreen AM, Mohammed SF, Mobeireek AF, Alkattan K, Chisti MA, Luzina IG, Al-Owain M, Weheba I, Abdelsayed AM, Ramzan K, Janssen LJ, Conca W, Alaiya A, Collison KS, Meyer BF, Atamas SP, Khabar KS, Hasday JD, Al-Mohanna F.

Eur Respir J. 2019 Jul 18;54(1). pii: 1802041. doi: 10.1183/13993003.02041-2018. Print 2019 Jul.

2.

Effectiveness of intralesional vitamin D3 injection in the treatment of common warts: Single-blinded placebo-controlled study.

Kareem IMA, Ibrahim IM, Mohammed SFF, Ahmed AA.

Dermatol Ther. 2019 May;32(3):e12882. doi: 10.1111/dth.12882. Epub 2019 Apr 16.

PMID:
30920098
3.

Reproducibility of Semi-automated Three-dimensional Volumetric Analysis using Cardiac Computed Tomography in Patients With Left Ventricular Assist Device.

Gill GS, Weissman G, Meirovich YF, Medvedofsky D, Mohammed SF, Waksman R, Garcia-Garcia HM.

Cardiovasc Revasc Med. 2019 May;20(5):381-386. doi: 10.1016/j.carrev.2019.01.024. Epub 2019 Jan 23.

PMID:
30772192
4.

Idiopathic pleuroparenchymal fibroelastosis: The first case to be managed with a successful lung transplant at King Faisal Specialist Hospital and Research Center, Riyadh.

Aljefri NA, Abothenain FF, Hussein AM, Saleh W, Alkattan K, Mohammed SF, Alhajji M.

Ann Thorac Med. 2019 Jan-Mar;14(1):94-98. doi: 10.4103/atm.ATM_106_18.

5.

Renin-Angiotensin Inhibition and Outcomes in Nursing Home Residents With Heart Failure.

Arundel C, Sheriff HM, Lam PH, Mohammed SF, Jones LG, Jurgens CY, Morgan CJ, Faselis C, Allman RM, Fonarow GC, Ahmed A.

Am J Ther. 2018 Oct 31. doi: 10.1097/MJT.0000000000000836. [Epub ahead of print]

PMID:
30299270
6.

Spironolactone and Outcomes in Older Patients with Heart Failure and Reduced Ejection Fraction.

Bayoumi E, Lam PH, Dooley DJ, Singh S, Faselis C, Morgan CJ, Patel S, Sheriff HM, Mohammed SF, Palant CE, Pitt B, Fonarow GC, Ahmed A.

Am J Med. 2019 Jan;132(1):71-80.e1. doi: 10.1016/j.amjmed.2018.09.011. Epub 2018 Sep 19.

PMID:
30240686
7.

Digoxin use and lower risk of 30-day all-cause readmission in older patients with heart failure and reduced ejection fraction receiving β-blockers.

Lam PH, Bhyan P, Arundel C, Dooley DJ, Sheriff HM, Mohammed SF, Fonarow GC, Morgan CJ, Aronow WS, Allman RM, Waagstein F, Ahmed A.

Clin Cardiol. 2018 Mar;41(3):406-412. doi: 10.1002/clc.22889. Epub 2018 Mar 22.

8.

Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.

Lam PH, Dooley DJ, Deedwania P, Singh SN, Bhatt DL, Morgan CJ, Butler J, Mohammed SF, Wu WC, Panjrath G, Zile MR, White M, Arundel C, Love TE, Blackman MR, Allman RM, Aronow WS, Anker SD, Fonarow GC, Ahmed A.

J Am Coll Cardiol. 2017 Oct 10;70(15):1861-1871. doi: 10.1016/j.jacc.2017.08.022.

9.

Zooming in on the Microvasculature in Heart Failure With Preserved Ejection Fraction.

Mohammed SF, Majure DT, Redfield MM.

Circ Heart Fail. 2016 Jul;9(7). pii: e003272. doi: 10.1161/CIRCHEARTFAILURE.116.003272. No abstract available.

10.

Immature mediastinal teratoma with unusual histopathology: A case report of multi-lineage, somatic-type malignant transformation and a review of the literature.

Mustafa OM, Mohammed SF, Aljubran A, Saleh WN.

Medicine (Baltimore). 2016 Jun;95(26):e3378. doi: 10.1097/MD.0000000000003378. Review.

12.

Inotropic agents use in patients hospitalized with acute decompensated heart failure: a retrospective analysis from a 22-year registry in a Middle-Eastern Country (1991-2013).

Aljundi AHS, Mohammed SFK, Patel A, Singh R, Arabi A, AlBinali HA, Al Suwaidi J.

BMC Cardiovasc Disord. 2016 Feb 19;16:47. doi: 10.1186/s12872-016-0223-5.

13.

Response to Letters Regarding Article, "Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction".

Mohammed SF, Redfield MM.

Circulation. 2015 Oct 20;132(16):e206. doi: 10.1161/CIRCULATIONAHA.115.017050. No abstract available.

14.

Response to letter regarding article, "right ventricular function in heart failure with preserved ejection fraction: a community-based study".

Mohammed SF, Forfia P, Redfield MM.

Circulation. 2015 Sep 29;132(13):e161. doi: 10.1161/CIRCULATIONAHA.115.016481. No abstract available.

PMID:
26416634
15.

Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction.

Zakeri R, Mohammed SF.

Curr Heart Fail Rep. 2015 Oct;12(5):295-301. doi: 10.1007/s11897-015-0267-3. Review.

PMID:
26338372
16.
17.

Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.

Mohammed SF, Hussain S, Mirzoyev SA, Edwards WD, Maleszewski JJ, Redfield MM.

Circulation. 2015 Feb 10;131(6):550-9. doi: 10.1161/CIRCULATIONAHA.114.009625. Epub 2014 Dec 31.

18.

Control of histone H3 phosphorylation by CaMKIIδ in response to haemodynamic cardiac stress.

Awad S, Al-Haffar KM, Marashly Q, Quijada P, Kunhi M, Al-Yacoub N, Wade FS, Mohammed SF, Al-Dayel F, Sutherland G, Assiri A, Sussman M, Bers D, Al-Habeeb W, Poizat C.

J Pathol. 2015 Mar;235(4):606-18. doi: 10.1002/path.4489. Epub 2014 Dec 17.

19.

Right ventricular function in heart failure with preserved ejection fraction: a community-based study.

Mohammed SF, Hussain I, AbouEzzeddine OF, Takahama H, Kwon SH, Forfia P, Roger VL, Redfield MM.

Circulation. 2014 Dec 23;130(25):2310-20. doi: 10.1161/CIRCULATIONAHA.113.008461. Epub 2014 Nov 12. Erratum in: Circulation. 2015 Apr 28;131(17):e424. Abou Ezzeddine, Omar F [corrected to AbouEzzeddine, Omar F].

20.

Resting ventricular-vascular function and exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.

Mohammed SF, Borlaug BA, McNulty S, Lewis GD, Lin G, Zakeri R, Semigran MJ, LeWinter M, Hernandez AF, Braunwald E, Redfield MM.

Circ Heart Fail. 2014 Jul;7(4):580-9. doi: 10.1161/CIRCHEARTFAILURE.114.001192. Epub 2014 May 15.

21.

Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction.

Mohammed SF, Mirzoyev SA, Edwards WD, Dogan A, Grogan DR, Dunlay SM, Roger VL, Gertz MA, Dispenzieri A, Zeldenrust SR, Redfield MM.

JACC Heart Fail. 2014 Apr;2(2):113-22. doi: 10.1016/j.jchf.2013.11.004.

22.
23.

Ocular manifestations of Behçet's disease in Jordanian patients.

Abu-Ameerh MA, Mohammed SF, Mohammad MT, Ababneh OH, Al-Bdour MD.

Saudi J Ophthalmol. 2013 Oct;27(4):247-51. doi: 10.1016/j.sjopt.2013.06.012. Epub 2013 Jul 1.

24.

Anti-remodeling effects of rapamycin in experimental heart failure: dose response and interaction with angiotensin receptor blockade.

Bishu K, Ogut O, Kushwaha S, Mohammed SF, Ohtani T, Xu X, Brozovich FV, Redfield MM.

PLoS One. 2013 Dec 3;8(12):e81325. doi: 10.1371/journal.pone.0081325. eCollection 2013.

25.

Impact of atrial fibrillation on exercise capacity in heart failure with preserved ejection fraction: a RELAX trial ancillary study.

Zakeri R, Borlaug BA, McNulty SE, Mohammed SF, Lewis GD, Semigran MJ, Deswal A, LeWinter M, Hernandez AF, Braunwald E, Redfield MM.

Circ Heart Fail. 2014 Jan;7(1):123-30. doi: 10.1161/CIRCHEARTFAILURE.113.000568. Epub 2013 Oct 25.

26.

Electronic structure of CaCO₃: a Compton scattering study.

Mohammed SF, Mohammad FM, Sahariya J, Mund HS, Bhamu KC, Ahuja BL.

Appl Radiat Isot. 2013 Feb;72:64-7. doi: 10.1016/j.apradiso.2012.10.006. Epub 2012 Oct 17.

PMID:
23208233
27.

Comorbidity and ventricular and vascular structure and function in heart failure with preserved ejection fraction: a community-based study.

Mohammed SF, Borlaug BA, Roger VL, Mirzoyev SA, Rodeheffer RJ, Chirinos JA, Redfield MM.

Circ Heart Fail. 2012 Nov;5(6):710-9. doi: 10.1161/CIRCHEARTFAILURE.112.968594. Epub 2012 Oct 17.

28.

PhosphdiesteRasE-5 Inhibition to Improve CLinical Status and EXercise Capacity in Diastolic Heart Failure (RELAX) trial: rationale and design.

Redfield MM, Borlaug BA, Lewis GD, Mohammed SF, Semigran MJ, Lewinter MM, Deswal A, Hernandez AF, Lee KL, Braunwald E; Heart Failure Clinical Research Network.

Circ Heart Fail. 2012 Sep 1;5(5):653-9. No abstract available.

29.

Diastolic stiffness as assessed by diastolic wall strain is associated with adverse remodelling and poor outcomes in heart failure with preserved ejection fraction.

Ohtani T, Mohammed SF, Yamamoto K, Dunlay SM, Weston SA, Sakata Y, Rodeheffer RJ, Roger VL, Redfield MM.

Eur Heart J. 2012 Jul;33(14):1742-9. doi: 10.1093/eurheartj/ehs135. Epub 2012 May 29.

30.

Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo.

Bishu K, Hamdani N, Mohammed SF, Kruger M, Ohtani T, Ogut O, Brozovich FV, Burnett JC Jr, Linke WA, Redfield MM.

Circulation. 2011 Dec 20;124(25):2882-91. doi: 10.1161/CIRCULATIONAHA.111.048520. Epub 2011 Dec 5.

31.

Variable phenotype in murine transverse aortic constriction.

Mohammed SF, Storlie JR, Oehler EA, Bowen LA, Korinek J, Lam CS, Simari RD, Burnett JC Jr, Redfield MM.

Cardiovasc Pathol. 2012 May-Jun;21(3):188-98. doi: 10.1016/j.carpath.2011.05.002. Epub 2011 Jul 18.

32.

Mineralocorticoid accelerates transition to heart failure with preserved ejection fraction via "nongenomic effects".

Mohammed SF, Ohtani T, Korinek J, Lam CS, Larsen K, Simari RD, Valencik ML, Burnett JC Jr, Redfield MM.

Circulation. 2010 Jul 27;122(4):370-8. doi: 10.1161/CIRCULATIONAHA.109.915215. Epub 2010 Jul 12.

33.
34.

Nesiritide in acute decompensated heart failure: current status and future perspectives.

Mohammed SF, Korinek J, Chen HH, Burnett JC, Redfield MM.

Rev Cardiovasc Med. 2008 Summer;9(3):151-8. Review.

35.

Insights into natriuretic peptides in heart failure: an update.

Korinek J, Boerrigter G, Mohammed SF, Burnett JC Jr.

Curr Heart Fail Rep. 2008 Jun;5(2):97-104. Review.

PMID:
18765080
36.

Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines.

Shapiro BP, Owan TE, Mohammed SF, Meyer DM, Mills LD, Schalkwijk CG, Redfield MM.

Circulation. 2008 Sep 2;118(10):1002-10. doi: 10.1161/CIRCULATIONAHA.108.777326. Epub 2008 Aug 18.

37.

Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model.

Shapiro BP, Lam CS, Patel JB, Mohammed SF, Kruger M, Meyer DM, Linke WA, Redfield MM.

Hypertension. 2007 Sep;50(3):503-11. Epub 2007 Jul 9.

PMID:
17620524
38.

Vibrational and thermal studies of the complexes (NH4)[VO(O2)2(phen)].2H2O and (NH4)[V(O2)3(phen)].2H2O.

Barakat AS, Gaballa AS, Mohammed SF, Teleb SM.

Spectrochim Acta A Mol Biomol Spectrosc. 2005 Dec;62(4-5):814-8.

PMID:
16303628
39.

Elastomeric valves, a new design.

Hulsbergen MH, Topaz S, Kumar A, Bishop ND, Shelton A, Granger S, Chiang BY, De Boer L, Luikenaar RA, Mohammed SF, et al.

Int J Artif Organs. 1995 Apr;18(4):203-9.

PMID:
8530200
40.

Dynamics of platelet interaction with surfaces in steady flow conditions.

Richardson PD, Mohammed SF, Mason RG, Steiner M, Kane R.

Trans Am Soc Artif Intern Organs. 1979;25:147-51. No abstract available.

PMID:
524574
41.

Multiple active forms of thrombin: binding to platelets and effects on platelet function.

Mohammed SF, Whitworth C, Chuang HY, Lundblad RL, Mason RG.

Proc Natl Acad Sci U S A. 1976 May;73(5):1660-3.

Supplemental Content

Loading ...
Support Center